170 results
Page 3 of 9
8-K
EX-1.1
2bgdq 8i7ovdwzei
26 Jan 21
Invitae Announces Pricing of Public Offering of Common Stock
4:12pm
424B5
1e0 3z5hx0q
25 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
fgcrqui1lcam7
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K
EX-99.2
kwji37j27
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
lhsdmro88r0po
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
EX-99.1
03cmytkqwslrmo rgv
12 Jan 21
Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Volume
6:06am
8-K/A
EX-99.1
hzxsksvd ivp
23 Nov 20
Consolidated Financial Statements
12:00am
8-K
EX-10.3
rnba83
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
hxx5qc
28 Aug 20
Prospectus supplement
4:31pm